Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions demonstrate high engagement through references to statistics like a 22% reduction in breast cancer risk and citations of the meta-analysis involving over 14,000 women. Words such as 'great news' and phrases like 'shatters misconception' convey excitement and impact, illustrating a consensus that this research could significantly influence understanding and treatment practices.
Most discussions strongly support the findings, emphasizing the protective effect of estrogen therapy on breast cancer risk.
The posts show high interest, highlighting new research and emphasizing its significance for women’s health.
Many comments reference specific studies, statistics, and implications, indicating deep engagement with the topic.
The overall tone suggests that these findings could influence clinical practices and public perceptions about hormone replacement therapy.
Estrogen therapy alone (without progestin) reduces breast cancer by 22% - findings of new 14,000+ person meta-analysis of 10 randomized trials. https://t.co/5BWyPvqJ5P
Great news from Breast Cancer Research and Treatment journal. They looked at 14,000 women who used estrogen-only HRT in a meta analysis of randomised controlled trials and found a 23% REDUCTION in risk of breast cancer. https://t.co/W41rBE6zlm
@lairdwd2 @MarbleBenjamin @EricawithaC13 @MartyMakary @US_FDA HRT isn’t necessarily bad. What dark sides have you seen? I get what you’re saying but it’s an important topic. https://t.co/CGonKBVP5a
@rutihersh @liti_gilad @ArielaGoesFake תבדקי קצת מחקרים חדשים. חלקם מראים אפילו ירידה בסיכון לסרטן. למשל המטא-אנליזה הזו. לגבי היתרונות הם כה משכנעים שאני בעד לכל מי שיכולה. https://t.co/Dt4E8yResu
https://t.co/OZXAuSdfKs
Conclusion: The totality of randomized clinical trial evidence supports a conclusion that estrogen-alone use significantly reduces breast cancer incidence. https://t.co/9EH6UvdY1d 2024
A new meta-analysis shows that not only are estrogens not linked to increased breast cancer risk, but they may actually reduce it. This challenges the common belief that hormone therapy increases risk. The study…
Welcome to the second season of Sala de Espera. In this episode, Dr. Nicols Reyes speaks with Dr. Daniela Julian about the critical yet often overlooked topic of cardiovascular health in women aged 35 to 49. Discover…
@rutihersh @liti_gilad @ArielaGoesFake תבדקי קצת מחקרים חדשים. חלקם מראים אפילו ירידה בסיכון לסרטן. למשל המטא-אנליזה הזו. לגבי היתרונות הם כה משכנעים שאני בעד לכל מי שיכולה. https://t.co/Dt4E8yResu
@lairdwd2 @MarbleBenjamin @EricawithaC13 @MartyMakary @US_FDA HRT isn’t necessarily bad. What dark sides have you seen? I get what you’re saying but it’s an important topic. https://t.co/CGonKBVP5a
Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis | Breast Cancer Research and Treatment https://t.co/W3C1i6VN8m
@Liz_ORiordan this is the polar opposite of what I see and hear in clinic and yet it’s being talked about today. I’d love to hear your thoughts on it? https://t.co/1obgyFRJi0
New findings reveal a 22% reduction in breast cancer with Estrogen Therapy, spanning over 14,000 women across randomized trials! This meta-analysis shatters the misconception of estrogen's link to breast cancer, marking a victory for women's health!
Conclusion The totality of randomized clinical trial evidence supports a conclusion that estrogen-alone use significantly reduces breast cancer incidence. Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis Research Published: 23 April 2024
https://t.co/OZXAuSdfKs
RT @KillenMd: Estrogen therapy alone (without progestin) reduces breast cancer by 22% - findings of new 14,000+ person meta-analysis of 10…
RT @KillenMd: Estrogen therapy alone (without progestin) reduces breast cancer by 22% - findings of new 14,000+ person meta-analysis of 10…
RT @MenoScandal: Great news from Breast Cancer Research and Treatment journal. They looked at 14,000 women who used estrogen-only HRT in a…
RT @MenoScandal: Great news from Breast Cancer Research and Treatment journal. They looked at 14,000 women who used estrogen-only HRT in a…
RT @MenoScandal: Great news from Breast Cancer Research and Treatment journal. They looked at 14,000 women who used estrogen-only HRT in a…
RT @MenoScandal: Great news from Breast Cancer Research and Treatment journal. They looked at 14,000 women who used estrogen-only HRT in a…
Great news from Breast Cancer Research and Treatment journal. They looked at 14,000 women who used estrogen-only HRT in a meta analysis of randomised controlled trials and found a 23% REDUCTION in risk of breast cancer. https://t.co/W41rBE6zlm
RT @KillenMd: Estrogen therapy alone (without progestin) reduces breast cancer by 22% - findings of new 14,000+ person meta-analysis of 10…
RT @KillenMd: Estrogen therapy alone (without progestin) reduces breast cancer by 22% - findings of new 14,000+ person meta-analysis of 10…
Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis Rowan T Chlebowski et al. Breast Cancer Res Treat. 2024.
Conclusion: The totality of randomized clinical trial evidence supports a conclusion that estrogen-alone use significantly reduces breast cancer incidence. https://t.co/9EH6UvdY1d 2024
RT @KillenMd: Estrogen therapy alone (without progestin) reduces breast cancer by 22% - findings of new 14,000+ person meta-analysis of 10…
RT @KillenMd: Estrogen therapy alone (without progestin) reduces breast cancer by 22% - findings of new 14,000+ person meta-analysis of 10…
RT @KillenMd: Estrogen therapy alone (without progestin) reduces breast cancer by 22% - findings of new 14,000+ person meta-analysis of 10…
Estrogen therapy alone (without progestin) reduces breast cancer by 22% - findings of new 14,000+ person meta-analysis of 10 randomized trials. https://t.co/5BWyPvqJ5P
estrogen-alone use significantly reduces breast cancer incidence. https://t.co/SwCigNmbMP
AM
RM
DD
M
T
DJ
P
YM
M
D
C
AS
NS
C
J
AB
DM
JP
DW
PM